what is semaglutide face Ozempic Face: It & How to Treat It What is Ozempic Face and

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice

Weight change tends to follow gradually with proper titration and monitoring

The most robust clinical evidence arguably originates from the large cardiovascular outcomes trials (CVOTs) completed for most GLP-1 RAs, of which the latest showed a significant relative risk reduction (RRR) of 39% (HR) with once-weekly efpeglenatide on HF requiring hospitalisation, corroborating a meta-analysis which found a significant RRR across eight GLP-1 RA CVOTs of 11%

Routine liver enzyme monitoring is not required for otherwise healthy patients taking GLP-1 medications